415 related articles for article (PubMed ID: 36847536)
1. The Colorectal Cancer Microbiota Alter Their Transcriptome To Adapt to the Acidity, Reactive Oxygen Species, and Metabolite Availability of Gut Microenvironments.
Lamaudière MTF; Arasaradnam R; Weedall GD; Morozov IY
mSphere; 2023 Apr; 8(2):e0062722. PubMed ID: 36847536
[TBL] [Abstract][Full Text] [Related]
2. The Colorectal Cancer Gut Environment Regulates Activity of the Microbiome and Promotes the Multidrug Resistant Phenotype of ESKAPE and Other Pathogens.
Lamaudière MTF; Arasaradnam R; Weedall GD; Morozov IY
mSphere; 2023 Apr; 8(2):e0062622. PubMed ID: 36847529
[TBL] [Abstract][Full Text] [Related]
3. Host-microbiota interactions contributing to the heterogeneous tumor microenvironment in colorectal cancer.
Li X; Wu D; Li Q; Gu J; Gao W; Zhu X; Yin W; Zhu R; Zhu L; Jiao N
Physiol Genomics; 2024 Feb; 56(2):221-234. PubMed ID: 38073489
[TBL] [Abstract][Full Text] [Related]
4. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
5. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
6. The Role of the Microbiome in the Etiopathogenesis of Colon Cancer.
El Tekle G; Andreeva N; Garrett WS
Annu Rev Physiol; 2024 Feb; 86():453-478. PubMed ID: 38345904
[TBL] [Abstract][Full Text] [Related]
7. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer.
Qu R; Zhang Y; Ma Y; Zhou X; Sun L; Jiang C; Zhang Z; Fu W
Adv Sci (Weinh); 2023 Aug; 10(23):e2205563. PubMed ID: 37263983
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of intestinal microbiota and host gene expression in colorectal cancer patients.
Chen Y; Si H; Bao B; Li S; Teng D; Yan Y; Hu S; Xu Y; Du X
J Med Microbiol; 2022 Sep; 71(9):. PubMed ID: 36136380
[No Abstract] [Full Text] [Related]
9. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
Avuthu N; Guda C
Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
[TBL] [Abstract][Full Text] [Related]
10. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment.
Hanus M; Parada-Venegas D; Landskron G; Wielandt AM; Hurtado C; Alvarez K; Hermoso MA; López-Köstner F; De la Fuente M
Front Immunol; 2021; 12():612826. PubMed ID: 33841394
[TBL] [Abstract][Full Text] [Related]
11. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer.
Ahmad Kendong SM; Raja Ali RA; Nawawi KNM; Ahmad HF; Mokhtar NM
Front Cell Infect Microbiol; 2021; 11():744606. PubMed ID: 34966694
[TBL] [Abstract][Full Text] [Related]
12. The roles of microbial products in the development of colorectal cancer: a review.
Fang Y; Yan C; Zhao Q; Xu J; Liu Z; Gao J; Zhu H; Dai Z; Wang D; Tang D
Bioengineered; 2021 Dec; 12(1):720-735. PubMed ID: 33618627
[TBL] [Abstract][Full Text] [Related]
13. Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer.
Zou S; Yang C; Zhang J; Zhong D; Meng M; Zhang L; Chen H; Fang L
J Transl Med; 2024 Feb; 22(1):175. PubMed ID: 38369542
[TBL] [Abstract][Full Text] [Related]
14. Interaction between Host MicroRNAs and the Gut Microbiota in Colorectal Cancer.
Yuan C; Burns MB; Subramanian S; Blekhman R
mSystems; 2018; 3(3):. PubMed ID: 29795787
[TBL] [Abstract][Full Text] [Related]
15. Faeces from malnourished colorectal cancer patients accelerate cancer progression.
Chao X; Lei Z; Hongqin L; Ziwei W; Dechuan L; Weidong D; Lu X; Haitao C; Bo Z; Haixing J; Qinghua Y
Clin Nutr; 2022 Mar; 41(3):632-644. PubMed ID: 35124471
[TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of the mouse fecal microbiome and metabolome reveal dynamic phenotypes in the development of colorectal cancer.
Liu J; Qi M; Qiu C; Wang F; Xie S; Zhao J; Wu J; Song X
Front Microbiol; 2022; 13():1021325. PubMed ID: 36246263
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer.
Li R; Zhou R; Wang H; Li W; Pan M; Yao X; Zhan W; Yang S; Xu L; Ding Y; Zhao L
Cell Death Differ; 2019 Nov; 26(11):2447-2463. PubMed ID: 30850734
[TBL] [Abstract][Full Text] [Related]
18. Integrated study of metabolomics and gut metabolic activity from ulcerative colitis to colorectal cancer: The combined action of disordered gut microbiota and linoleic acid metabolic pathway might fuel cancer.
Tang Q; Cang S; Jiao J; Rong W; Xu H; Bi K; Li Q; Liu R
J Chromatogr A; 2020 Oct; 1629():461503. PubMed ID: 32858455
[TBL] [Abstract][Full Text] [Related]
19. Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer.
Zhang SL; Cheng LS; Zhang ZY; Sun HT; Li JJ
Pharmacol Res; 2023 Feb; 188():106633. PubMed ID: 36574857
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between gut microbiota and metastasis in colorectal cancer: implication of neutrophil extracellular traps.
Wu J; Dong W; Pan Y; Wang J; Wu M; Yu Y
Front Immunol; 2023; 14():1296783. PubMed ID: 37936694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
